Successful treatment of hyperglycemia with liraglutide in a hospitalized 27-year-old patient with schizophrenia: A case report

Figure 1 Dosage of insulin and liraglutide, and change of the blood glucose. A: Dosage of insulin and liraglutide. Treatment with continuous subcutaneous insulin infusion for three days, than we applied an add-on treatment with liraglutide. After the liraglutide dosage was increased to 1.8 mg/d, all insulin was stopped; B: Change of the blood glucose. Blood glucose levels were measured five times each day, including determination of fasting blood glucose and 2 h postprandial blood glucose after three meals. FBG: Fasting blood glucose; PBG: Postprandial blood glucose.

Figure 2 Potential pathways leading to carbohydrate intolerance and diabetes in patients receiving atypical antipsychotic medications. AGRP: Agouti-related peptide; NPY: Neuropeptide Y.